Find Academic Supervisors

Marcelo FeboView profile

Associate Professor

• Neuroimaging
• Neurological Disorders
• Psychiatric Brain Disorders
• +4 more

Marcelo Febo, Ph.D., is an Associate Professor and Director of Translational Research Imaging in the Department of Psychiatry at the University of Florida College of Medicine. His research focuses on functional connectivity in rodent models of neurological and psychiatric disorders, leveraging high-field MRI to study mechanisms underlying Alzheimer’s, traumatic brain injury (TBI), and addiction. He holds a B.Sc. in Biology and a Ph.D. in Physiology from the University of Puerto Rico, followed by postdoctoral training in neuroimaging at the University of Massachusetts Medical School. Education: B.Sc. in Biology, University of Puerto Rico Ph.D. in Physiology, University of Puerto Rico Postdoctoral Fellow in Neuroimaging, University of Massachusetts Medical School Research Interests: Dr. Febo’s laboratory investigates how functional connectivity changes in rodent brains relate to behavioral outcomes in aging, TBI, and addiction. Key areas include: Beta-amyloid’s impact on resting-state networks Functional reorganization post-TBI Neuroimaging of drug misuse mechanisms His work integrates MRI, behavioral assays, and statistical analysis to evaluate therapeutic candidates. Grants & Advising: Though specific grants are not listed, his lab’s translational focus suggests involvement in collaborative initiatives like the TOP-NT Consortium. No advisees are explicitly mentioned in the text. Labs & Teams: Directs the Translational Research Imaging Lab, emphasizing preclinical neuroimaging and behavioral studies in rodent models.

David WrightView profile

Professor

• Emergency Medicine
• Traumatic Brain Injury
• Sepsis Management
• +4 more

David Wright is a Professor in the Department of Emergency Medicine at Emory University’s School of Medicine, with an additional affiliation in the Gangarosa Department of Environmental Health. His work bridges clinical practice and research, focusing on emergency care innovations, traumatic neurological injuries, and sepsis management. Key research areas include AI-driven diagnostics, non-invasive imaging techniques, and biomarker development for critical conditions like stroke and traumatic brain injury. His research interests emphasize translational medicine, with a particular focus on improving emergency department protocols through technologies such as nonmydriatic ocular fundus imaging and machine learning systems. He has contributed to large-scale studies like the ENRICH trial on intracerebral hemorrhage management and the SUBSPACE consortium analyzing immune dysregulation in critical illness. Recent publications highlight advancements in stroke risk prediction, surgical timing for intracerebral hemorrhages, and sepsis biomarker frameworks. His work frequently integrates clinical data with computational methods to enhance diagnostic accuracy and patient outcomes in emergency settings. No scientific awards are explicitly listed in the provided text. His research extends to global health initiatives, including malaria diagnostics and post-COVID-19 critical care protocols. Collaborations span disciplines from neurology to software engineering, reflecting his interdisciplinary approach to solving complex medical challenges.

Duwage AlwisView profile

Lecturer

• Neuroscience
• Traumatic Brain Injury
• Sensory Processing
• +3 more

Duwage Alwis is a Lecturer in the Faculty of Medicine, Nursing and Health Sciences at Monash University, affiliated with the Faculty Office. His research focuses on neuroscience, particularly traumatic brain injury (TBI), sensory processing, and neurophysiological mechanisms. He investigates how neural systems integrate sensory information and respond to injury, with a focus on white matter dynamics, lipid gradients, and neural encoding in rodent models. His work employs advanced imaging techniques and interdisciplinary approaches, collaborating with researchers in neurochemistry and cellular biology. Alwis has contributed to over 16 peer-reviewed publications since 2012, including studies on multisensory integration, TBI-induced cellular changes, and neuroimaging methodologies. Notable outputs include investigations into somatosensory encoding enhancement via auditory input and the long-term effects of TBI on inhibitory neurons. His research bridges clinical and experimental neuroscience, aiming to advance understanding of neurological disorders. No scientific awards or grants are explicitly listed in the provided data. Collaborations include work with colleagues such as Dr. Hartnell, Dr. Rajan, and Dr. Hackett. While specific student advisees are not mentioned, his research activities suggest involvement in training graduate students in experimental neuroscience.

• Imaging Biomarkers
• MRI
• PET
• +6 more

David Wright is an Associate Professor (Research) in the Department of Neuroscience at Monash University, specializing in advanced neuroimaging techniques for neurological diseases. His work focuses on developing MRI-based biomarkers to study traumatic brain injury (TBI), epilepsy, and neurodegenerative disorders. He leads projects such as the NIH-funded Translational platform for epilepsy therapy and biomarker discovery and the Glymphatic System: Novel Biomarker of Disease Severity and Therapeutic Target . Affiliations: Monash Biomedical Imaging (MBI), Central Clinical School. Research Interests: Imaging biomarkers, MRI methodology, TBI pathophysiology, neuroinflammation, and neurodegenerative biomarkers. His research highlights include identifying novel MRI metrics for axonal injury in TBI and demonstrating the role of pre-existing infections (e.g., Toxoplasma gondii) in exacerbating brain damage post-TBI. He collaborates internationally on harmonizing preclinical neuroimaging data to improve translational studies. Key Projects: Translational platform for epilepsy therapy (NIH, 2022–2026) Glymphatic System Biomarkers (2022–2024) His lab, the Wright Group at Monash, focuses on imaging-driven solutions for neurological disorders, with emphasis on clinical translation. Recent work explores CD39-targeted therapies for stroke and glymphatic dysfunction in ALS.

Mustafa O. GulerView profile

Teaching Professor

• Peptide Nanomaterials
• Biomedical Engineering
• Drug Delivery Systems
• +2 more

Dr. Mustafa O. Guler is Senior Instructional Professor and Director of Experiential Learning at the University of Chicago's Pritzker School of Molecular Engineering. A Fellow of the Royal Society of Chemistry, his research develops peptide-based biomaterials for therapeutic applications. His laboratory focuses on molecular engineering of self-assembling peptide systems for regenerative medicine, drug delivery, and immunoengineering. Key innovations include: glycosaminoglycan-mimetic nanofibers for cartilage regeneration; neuroactive scaffolds for spinal cord repair; and antigen-presenting nanomaterials for cancer immunotherapy. Materials are designed through computational modeling and validated in disease models. Publications demonstrate cross-disciplinary integration of peptide chemistry, nanomaterial science, and biomedical engineering. Recent work emphasizes translational applications in ocular drug delivery, neural regeneration, and immunomodulation. He maintains editorial roles for Scientific Reports, RSC Advances, and Molecules.

• Neurodegenerative diseases
• Alzheimer’s disease
• Parkinson’s disease
• +4 more

Russell is a Professor in the Department of Neurology at the University of California, San Francisco (UCSF) School of Medicine. As a leading neuroscientist, he focuses on neurodegenerative diseases including Alzheimer's, Parkinson's, and Traumatic Brain Injury (TBI). He directs the Neurodegenerative Disease Research Center and leads the Russell Lab, integrating basic research with clinical translation. PhD in Neuroscience from Harvard University (2005) MD from Stanford University School of Medicine (2002) His research investigates neurodegenerative mechanisms using advanced neuroimaging, molecular biology, and computational modeling. Current projects explore tau protein aggregation, blood-brain barrier dysfunction in TBI, and neuroprotective CRISPR-based therapies. Recent publications emphasize machine learning applications in neurodegenerative diagnosis, novel biomarkers for ALS progression, and LRRK2 kinase inhibitors for Parkinson's treatment. Research trends show strong focus on translational medicine bridging basic science and clinical practice. NIH Director’s Pioneer Award (2024) Alzheimer’s Association Zenith Fellow (2023) Directed over $10M in NIH grants, advised 5 PhD students, and collaborates with the Gladstone Institutes. Current grants include a NINDS-funded study on TBI recovery mechanisms and a DoD grant exploring neuroprotection in combat-related injuries. Leads the Neurodegeneration Imaging Core and collaborates with the UCSF Memory and Aging Center. Future work focuses on developing AI-driven diagnostic platforms and gene-editing therapies for neurodegenerative diseases.

Mary WooView profile

Professor

• Heart Failure
• Brain-Heart Interactions
• Sleep Apnea
• +3 more

Mary Woo is a Professor at the UCLA School of Nursing researching brain-heart interactions in heart failure patients, where she identified specific brain injury sites. Her NIH-funded program (continuously since 1997) examines causes and treatments for cardiac-related brain injury. She mentors trainees across nursing, physiology, neurobiology, and medicine. Research expertise includes autonomic-cardiac regulation, heart failure complications, sleep apnea neurology, and neuroimaging (brain MRI, DTI, MRS). Publications document gray matter loss, hippocampal damage, blood-brain barrier dysfunction, and metabolic changes in cardiovascular and sleep-disordered patients. Honors include American Heart Association fellowship (1997), American Academy of Nursing fellowship (2001), AHA's Pillar of Cardiovascular Nursing Research award (2009), and NINR Director's Leadership Award (2013). She leads multiple NIH grants investigating brain injury mechanisms in heart failure and sleep apnea.

• Traumatic Brain Injury
• Spinal Cord Injury
• Cerebral Edema
• +5 more

Gary Schwartzbauer is an Associate Professor in the Department of Neurosurgery at the University of Maryland School of Medicine , with secondary appointments in Orthopaedics and Surgical Critical Care . He serves as the Director of the Neurotrauma Critical Care Unit (NTCC) at the R Adams Cowley Shock Trauma Center and holds clinical responsibilities in operating rooms and intensive care units. B.S. in Biophysics and Biochemistry from the University of Pittsburgh (1990, Summa Cum Laude) Ph.D. in Molecular, Cellular, and Developmental Biology from the University of Pittsburgh (1997) M.D. from the University of Maryland School of Medicine (2007) Postdoctoral fellowships at Children's Hospital of Pittsburgh (1997-1999) and Cincinnati Children's Hospital (1999-2003) Dr. Schwartzbauer specializes in traumatic and degenerative spine disease , traumatic brain injury , and brain tumors , with research focused on microvascular dysfunction in CNS injuries. His work explores therapies for cerebral edema in conditions like TBI, SCI, and cerebral malaria, emphasizing small molecule interventions. Recent publications highlight applications of augmented reality in neurosurgery and medical imaging for outcome prediction. His 15 most recent articles span neurotrauma , neurocritical care , spine surgery , and medical technology , including studies on glymphatic system changes after mTBI , AR-guided surgical tools , and trauma-induced thrombosis . Collaborative work with J. Marc Simard, M.D., Ph.D., and others dominates his publications. Co-valedictorian , University of Maryland School of Medicine President of AOA national medical honor society Clinically, Dr. Schwartzbauer integrates augmented reality for preoperative planning, combining his expertise in neurosurgery and critical care . His research bridges pre-clinical models and clinical investigations , aiming to reduce secondary injury in neurotrauma patients.

Jeremy HogeveenView profile

Associate Professor

• Cognitive Neuroscience
• Decision-Making
• Motivational Neurocircuitry
• +2 more

Jeremy Hogeveen is Associate Professor in the Department of Psychology at the University of New Mexico. His Cognitive Neuroscience Lab investigates decision-making circuits using fMRI and transcranial magnetic stimulation (TMS), with applications to psychiatric and neurological disorders. Dr. Hogeveen employs computational models to understand neural mechanisms and develop neuromodulation therapies. Research focuses on: Neural basis of explore-exploit decision-making Motivational neurocircuitry in mental health disorders Noninvasive neuromodulation techniques He currently advises graduate students Ethan Campbell and Teagan Mullins, along with research assistants Caitlin Enders and Cidney Robertson-Benta. Dr. Hogeveen teaches courses in Neuropsychology, Human Learning & Memory, and Data Science in Psychology & Neuroscience.

• Medical Imaging
• Magnetic Resonance Imaging (MRI)
• Nanoparticle Technology
• +5 more

Olav Haraldseth is a Professor and Director of the MI Lab at the Norwegian University of Science and Technology (NTNU), affiliated with the Department of Circulation and Medical Imaging within the Faculty of Medicine. He holds a PhD in Medicine (1992, NTNU) and an MD (1984, University of Bergen). His research focuses on advanced MRI techniques, nanoparticle development for imaging and drug delivery, and image-guided regenerative medicine. He has led major initiatives including the SFI Medical Imaging Centre (SFI), Norwegian Research School in Medical Imaging (MedIm), and national and international imaging networks like NorMIC and EATRIS. His work spans preclinical and clinical applications, with contributions to neuroimaging, cardiovascular MRI, and molecular imaging technologies. Key roles include former Dean for Research at NTNU’s Faculty of Medicine (2006-07), Head of Department (2005-05), and Vice-Head (2002-05). He has pioneered methods such as manganese-enhanced MRI and dynamic contrast-enhanced MRI for studying brain injury, myocardial viability, and tumor response to therapy. His leadership extends to national committees and European infrastructure projects like Euro-BioImaging and EATRIS. Research interests emphasize translational applications: functional MRI for brain activity mapping, multi-modal nanoparticles for simultaneous imaging and therapy, and MRI guidance in stem cell transplantation and regenerative therapies. His work bridges engineering, biology, and clinical practice, with over 100 publications in high-impact journals like Neurochemical Research , ACS Nano , and Journal of Magnetic Resonance Imaging .

• Neuroscience
• Traumatic Brain Injury
• Neurochemistry
• +1 more

Robert Vink is a research professor at James Cook University specializing in neuroscience and traumatic brain injury. His work focuses on neuroinflammation, neuroprotective agents, and therapeutic interventions for brain trauma. Research interests include neurochemistry of trauma, neuropharmacology (particularly magnesium-based therapies), neuropeptide signaling in injury responses, and experimental models of brain injury. Vink's publications demonstrate consistent focus on molecular mechanisms of traumatic brain injury, neuroprotective strategies, and experimental therapeutics. Key trends include neuroinflammation modulation, substance P antagonists, magnesium therapeutics, and rodent model validation for neurotrauma research. He collaborates extensively on neurotrauma research, particularly with institutions studying neurogenic inflammation. No specific laboratories, teams, or grant information is mentioned in available sources.

Jiming KongView profile

Professor

• Neurobiology
• Neurodegenerative Diseases
• Aging Biology
• +3 more

Dr. Jiming Kong is a Professor in the Department of Human Anatomy and Cell Science at the Max Rady College of Medicine, University of Manitoba, with cross-appointments in Psychiatry and the College of Pharmacy. His research focuses on neurodegenerative diseases, particularly Amyotrophic Lateral Sclerosis (ALS), aging mechanisms, and myelination processes. He holds prestigious awards including the New Investigator Award from the Heart and Stroke Foundation and the National Science and Technology Award for Distinguished Young Scientists of China. Education: PhD in Human Anatomy, Southern Medical University (1994) Master of Science in Human Anatomy, Southern Medical University (1986) Bachelor of Science in Medicine, Southwest Medical University (1983) Postdoctoral fellowships in Pharmacology, Anatomy, and Biochemistry (1998–2002) Research Interests: ALS pathogenesis and therapeutic development Oxidative stress in neurodegeneration Microglial roles in myelination Age-related neuronal vulnerability Grants and Labs: His lab has been continuously funded since 2002, focusing on SOD1 misfolding and myelin repair. He is affiliated with the Children’s Hospital Research Institute of Manitoba (CHRIM). Professional Contributions: Supervised over 130 papers, a book, and five book chapters. Active in training graduate students and postdoctoral fellows.

Jeff TwissView profile

Professor

• Neurobiology
• Neural Repair
• Axonal Regeneration
• +3 more

Jeff Twiss is a Professor and SmartState Chair in Childhood Neurotherapeutics at the University of South Carolina , affiliated with the McCausland College of Arts and Sciences and the Department of Biological Sciences . His research focuses on neurobiology , particularly axonal regeneration , RNA transport , and protein synthesis in neurons , aiming to restore neural function after injury. Research Interests: Twiss investigates how intrinsic neuronal mechanisms and extrinsic environmental factors influence neural repair . His work includes axonal mRNA localization , retrograde signaling , and RNA-binding protein dynamics , with applications in spinal cord injury and neurodegenerative diseases . Scientific Contributions: PI(3,5)P2 biosynthesis in oligodendrocyte differentiation Role of SUMOylation in axonal growth HDAC6 as a target for neural regeneration Grants & Awards: Funded by NIH , Department of Defense , US-Israel BSF , and the Adelson Medical Research Foundation , Twiss leads the Center for Childhood Neurotherapeutics .

• Medical imaging
• Neurology
• Cognitive neuroscience
• +3 more

Asta Kristine Håberg is a Professor at the Department of Neuromedicine and Movement Science , Norwegian University of Science and Technology (NTNU), affiliated with the Faculty of Medicine and Health Sciences . She is also Head of the Norwegian National Advisory Unit for functional MRI at St. Olav’s University Hospital and the Trondheim fMRI group , as well as leading the Center of Innovative Ultrasound Solutions (CIUS) . Medical doctor and PhD in Medicine (dr.med.) Specializes in medical imaging and spectroscopy , with a focus on cognition across the lifespan and neurological/neurosurgical conditions Extensive research in traumatic brain injury , dementia risk factors , and exercise interventions for brain aging Key methodologies include diffusion tensor imaging , functional MRI , and population-based studies Her recent publications (2025-2024) reveal a strong emphasis on: Neurodegenerative disease mechanisms (dementia, Alzheimer’s) Brain injury recovery (TAI, mTBI, thalamic connectivity) Neuroimaging biomarkers (white matter microstructure, diffusion MRI) Cognitive aging (occupational demands, retirement effects) Developmental neuroscience (prematurity, brain complexity) Neuroinflammation and neurodegeneration in trauma Labs/Teams: Trondheim fMRI group , CIUS (Center for Research-based Innovation) , and collaborations with HUNT Study and CENTER-TBI consortia.

Pratik MukherjeeView profile

Professor

• Neuroimaging
• Traumatic Brain Injury
• Neurodevelopmental Disorders
• +5 more

Pratik Mukherjee, MD, PhD, is a Professor in Residence in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco (UCSF) School of Medicine. He holds dual appointments in Radiology and Biomedical Imaging and serves as an attending neuroradiologist at UCSF. Dr. Mukherjee directs the Center for Imaging of Neurodegenerative Disease (CIND) based at the San Francisco VA Medical Center and the Neural Connectivity Laboratory (NCL) at UCSF China Basin. Dr. Mukherjee received his B.A. in Computer Science & Psychology from Yale University (1988), PhD in Neuroscience from Rockefeller University (1994), and MD from Cornell University (1995). He completed his internship in Internal Medicine at New York Hospital - Cornell Medical Center, followed by residency in Radiology and fellowship in Neuroradiology at Washington University Medical Center (completed 2002). His primary research focuses on neurodevelopmental disorders and traumatic brain injury (TBI) using advanced MRI techniques. His work centers on technical development, neuroscience, and clinical applications of imaging methods for mapping brain structure and function, with special emphasis on diffusion MRI for assessing white matter development and integrity and mapping axonal fiber pathways. His recent publications show a strong concentration on connectomics, biomarkers for TBI, and advanced neuroimaging techniques. Dr. Mukherjee has served as Principal or Co-Principal Investigator for numerous NIH-funded projects including TRACK-VA, Neural Mechanisms of Sensory OverResponsivity, and MRI Corticography. His research has also been supported by the Department of Defense, Simons Foundation, McDonnell Foundation, Dana Foundation, Wallace Research Foundation, GE Healthcare, and the GE-NFL Head Health Initiative. Medical Scientist Training Program Grant, National Institutes of Health (1988-95) S. Koide Memorial Fellowship, Rockefeller University (1994) Roentgen Resident/Fellow Research Award, Radiological Society of North America (1999) Berlex/ASNR Award in Basic Science Research, American Society of Neuroradiology (2001) As Principal Investigator of multiple major grants and co-investigator in the TRACK-TBI consortium, Dr. Mukherjee has mentored numerous researchers and secured over $10 million in research funding. His work with the Center for Imaging of Neurodegenerative Disease involves a multidisciplinary team of neuroscientists, radiologists, and engineers developing next-generation imaging techniques for neurodegenerative conditions. Future research directions include advancing ultra-high field MRI technologies and developing personalized connectomic approaches for neurological disorders.